With 0.58 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.81 million shares. The 52-week range on PCRX shows that it touched its highest point at $31.67 and its lowest point at $11.16 during that stretch. It currently has a 1-year price target of $28.57. Beta for the stock currently stands at 0.85.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PCRX was down-trending over the past week, with a drop of -5.16%, but this was up by 12.07% over a month. Three-month performance surged to 51.20% while six-month performance rose 81.14%. The stock lost -15.74% in the past year, while it has gained 33.55% so far this year. A look at the trailing 12-month EPS for PCRX yields -2.05 with Next year EPS estimates of 3.54. For the next quarter, that number is 0.84. This implies an EPS growth rate of 12.09% for this year and 12.46% for next year.
Float and Shares Shorts:
At present, 46.15 million PCRX shares are outstanding with a float of 44.09 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PCRX since 6 analysts follow the stock currently. There are 5 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $3.45278 being high and $3.00028 being low. For PCRX, this leads to a yearly average estimate of $3.138. Based on analyst estimates, the high estimate for the next quarter is $0.94 and the low estimate is $0.59. The average estimate for the next quarter is thus $0.78.
